This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEB6R0AQ_M.jpg
Bristol-Myers Squibb announced earnings per share of $1.46 on revenue of $11.07B. Analysts polled by Investing.com anticipated EPS of $1.41 on revenue of $10.72B.
Bristol-Myers Squibb shares are down 0% from the beginning of the year, still down 8.51% from its 52 week high of $67.80 set on February 6, 2020. They are under-performing the S&P Global 100 which is up 2.74% from the start of the year.
Bristol-Myers Squibb’s report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.
Abbott Labs had beat expectations on January 27 with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
